Teladoc (4LL) Stock Forecast & Price Target

9 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

4LL Analyst Ratings

Hold

4 Buy

13 Hold

0 Sell

Based on 17 analysts giving stock ratings to

Teladoc

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

4LL Stock 12 Month Forecast

Average Price Target

€6.60

▼(-15.34% Downside)

Based on 17 Wall Street analysts offering 12 month price targets for Teladoc in the last 3 months. The average price target is €6.60 with a high forecast of €9.10 and a low forecast of €4.77. The average price target represents a -15.34% change from the last price of €7.80.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"€3","10":"€10","4.75":"€4.75","6.5":"€6.5","8.25":"€8.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":9.10465668,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€9.10</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.603377372307692,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€6.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.76910588,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€4.77</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,4.75,6.5,8.25,10],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.692,5.954512052307693,6.217024104615385,6.479536156923077,6.742048209230769,7.004560261538462,7.267072313846153,7.529584366153846,7.792096418461538,8.054608470769232,8.317120523076923,8.579632575384615,8.842144627692306,{"y":9.10465668,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.692,5.762105951715976,5.832211903431952,5.902317855147929,5.9724238068639055,6.042529758579882,6.112635710295858,6.182741662011835,6.252847613727811,6.322953565443787,6.393059517159763,6.46316546887574,6.533271420591716,{"y":6.603377372307692,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.692,5.621008144615384,5.550016289230769,5.479024433846154,5.408032578461539,5.337040723076923,5.266048867692308,5.195057012307692,5.124065156923077,5.053073301538461,4.982081446153846,4.9110895907692305,4.8400977353846155,{"y":4.76910588,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.623,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.63,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.39,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.37,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.906,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.6,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.309,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.703,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.608,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.792,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.334,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.692,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€9.10

Average Price Target€6.60

Lowest Price Target€4.77

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Peter Warendorf

Barclays

€6.07

Hold

-22.18%

Downside

Reiterated

08/03/26

Barclays Sticks to Their Hold Rating for Teladoc (TDOC)

Daniel Grosslight

Citi

€9.54→€6.5

Hold

-16.62%

Downside

Reiterated

08/03/26

Teladoc price target lowered to $7.50 from $11 at CitiTeladoc price target lowered to $7.50 from $11 at Citi

Allen Lutz

Bank of America Securities

€9.1

Buy

16.73%

Upside

Reiterated

07/30/26

Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC), Fortrea Holdings Inc. (NASDAQ: FTRE) and uniQure (NASDAQ: QURE)

Richard Close

Canaccord Genuity

€9.54→€8.67

Buy

11.17%

Upside

Reiterated

07/30/26

Teladoc price target lowered to $10 from $11 at CanaccordTeladoc price target lowered to $10 from $11 at Canaccord

Brian Tanquilut

Jefferies

€7.8→€6.94

Hold

-11.07%

Downside

Reiterated

07/30/26

Teladoc price target lowered to $8 from $9 at JefferiesTeladoc price target lowered to $8 from $9 at Jefferies

Elizabeth Anderson CFA

Evercore ISI

€8.67→€6.5

Hold

-16.62%

Downside

Reiterated

07/30/26

Teladoc price target lowered to $7.50 from $10 at Evercore ISITeladoc price target lowered to $7.50 from $10 at Evercore ISI

David Grossman

Stifel Nicolaus

€4.77

Hold

-38.86%

Downside

Reiterated

07/30/26

Teladoc (TDOC) Receives a Hold from Stifel Nicolaus

Stan Berenshteyn

Wells Fargo

€5.2

Hold

-33.30%

Downside

Reiterated

07/30/26

Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC) and GE Healthcare Technologies Inc (NASDAQ: GEHC)

Jailendra Singh

Truist Financial

―

Hold

―

Reiterated

07/30/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Biogen (NASDAQ: BIIB), Teladoc (NYSE: TDOC) and Damora Therapeutics (NASDAQ: DMRA)

Ryan MacDonald

Needham

―

Hold

―

Reiterated

07/30/26

Teladoc: Mixed Business Performance and BetterHelp Growth Uncertainty Keep Ryan MacDonald at Hold

Sarah James

Cantor Fitzgerald

€8.67

Buy

11.17%

Upside

Reiterated

07/29/26

Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), Teladoc (TDOC)

Ryan Daniels

William Blair

―

Hold

―

Reiterated

07/29/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Teladoc (NYSE: TDOC) and Boston Scientific (NYSE: BSX)

Sean Dodge

BMO Capital

€4.34→€6.07

Hold

-22.18%

Downside

Assigned

07/29/26

Teladoc (TDOC) Receives a Hold from BMO Capital

David Larsen

BTIG

―

Hold

―

Assigned

07/29/26

Teladoc Maintained at Hold as Integrated Care Shows Modest Strength but BetterHelp Weakness and Lack of Clear Vertical Leadership Cap Long-Term Upside

David Roman

Goldman Sachs

€6.07→€6.94

Buy

-11.07%

Downside

Reiterated

05/27/26

Teladoc price target raised to $8 from $7 at Goldman SachsTeladoc price target raised to $8 from $7 at Goldman Sachs

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Peter Warendorf

Barclays

€6.07

Hold

-22.18%

Downside

Reiterated

08/03/26

Barclays Sticks to Their Hold Rating for Teladoc (TDOC)

Daniel Grosslight

Citi

€9.54→€6.5

Hold

-16.62%

Downside

Reiterated

08/03/26

Teladoc price target lowered to $7.50 from $11 at CitiTeladoc price target lowered to $7.50 from $11 at Citi

Allen Lutz

Bank of America Securities

€9.1

Buy

16.73%

Upside

Reiterated

07/30/26

Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC), Fortrea Holdings Inc. (NASDAQ: FTRE) and uniQure (NASDAQ: QURE)

Richard Close

Canaccord Genuity

€9.54→€8.67

Buy

11.17%

Upside

Reiterated

07/30/26

Teladoc price target lowered to $10 from $11 at CanaccordTeladoc price target lowered to $10 from $11 at Canaccord

Brian Tanquilut

Jefferies

€7.8→€6.94

Hold

-11.07%

Downside

Reiterated

07/30/26

Teladoc price target lowered to $8 from $9 at JefferiesTeladoc price target lowered to $8 from $9 at Jefferies

Elizabeth Anderson CFA

Evercore ISI

€8.67→€6.5

Hold

-16.62%

Downside

Reiterated

07/30/26

Teladoc price target lowered to $7.50 from $10 at Evercore ISITeladoc price target lowered to $7.50 from $10 at Evercore ISI

David Grossman

Stifel Nicolaus

€4.77

Hold

-38.86%

Downside

Reiterated

07/30/26

Teladoc (TDOC) Receives a Hold from Stifel Nicolaus

Stan Berenshteyn

Wells Fargo

€5.2

Hold

-33.30%

Downside

Reiterated

07/30/26

Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC) and GE Healthcare Technologies Inc (NASDAQ: GEHC)

Jailendra Singh

Truist Financial

―

Hold

―

Reiterated

07/30/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Biogen (NASDAQ: BIIB), Teladoc (NYSE: TDOC) and Damora Therapeutics (NASDAQ: DMRA)

Ryan MacDonald

Needham

―

Hold

―

Reiterated

07/30/26

Teladoc: Mixed Business Performance and BetterHelp Growth Uncertainty Keep Ryan MacDonald at Hold

Sarah James

Cantor Fitzgerald

€8.67

Buy

11.17%

Upside

Reiterated

07/29/26

Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), Teladoc (TDOC)

Ryan Daniels

William Blair

―

Hold

―

Reiterated

07/29/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Teladoc (NYSE: TDOC) and Boston Scientific (NYSE: BSX)

Sean Dodge

BMO Capital

€4.34→€6.07

Hold

-22.18%

Downside

Assigned

07/29/26

Teladoc (TDOC) Receives a Hold from BMO Capital

David Larsen

BTIG

―

Hold

―

Assigned

07/29/26

Teladoc Maintained at Hold as Integrated Care Shows Modest Strength but BetterHelp Weakness and Lack of Clear Vertical Leadership Cap Long-Term Upside

David Roman

Goldman Sachs

€6.07→€6.94

Buy

-11.07%

Downside

Reiterated

05/27/26

Teladoc price target raised to $8 from $7 at Goldman SachsTeladoc price target raised to $8 from $7 at Goldman Sachs

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

MLYSMineralys Therapeutics, Inc.

AMLXAmylyx Pharmaceuticals Inc

ZURAZura Bio

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Teladoc

3 Months

Richard CloseCanaccord Genuity

Success Rate

25/47 ratings generated profit

Average Return

+0.02%

Copying Richard Close's trades and holding each position for 3 Months would result in 53.19% of your transactions generating a profit, with an average return of +0.02% per trade.

1 Year

George HillDeutsche Bank

Success Rate

10/21 ratings generated profit

Average Return

+15.65%

Copying George Hill's trades and holding each position for 1 Year would result in 47.62% of your transactions generating a profit, with an average return of +15.65% per trade.

2 Years

George HillDeutsche Bank

Success Rate

11/21 ratings generated profit

Average Return

+37.50%

Copying George Hill's trades and holding each position for 2 Years would result in 52.38% of your transactions generating a profit, with an average return of +37.50% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

4LL Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 4LL has received 6 Buy Ratings, 15 Hold Ratings, and 0 Sell Ratings. 4LL average Analyst price target in the past 3 months is 6.60.

Each month's total comprises the sum of three months' worth of ratings.

4LL Financial Forecast

4LL Earnings Forecast

Next quarter’s earnings estimate for 4LL is -€0.18 with a range of -€0.22 to -€0.14. The previous quarter’s EPS was -€0.18. 4LL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.80% of the time in the same period. In the last calendar year 4LL has Performed in-line its overall industry.

4LL Sales Forecast

Next quarter’s sales forecast for 4LL is €520.66M with a range of €506.79M to €552.65M. The previous quarter’s sales results were €526.27M. 4LL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year 4LL has Performed in-line its overall industry.

4LL Stock Forecast FAQ

What is DE:4LL’s average 12-month price target, according to analysts?

Based on analyst ratings, Teladoc’s 12-month average price target is 6.60.

What is DE:4LL’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for DE:4LL, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Teladoc a Buy, Sell or Hold?

Teladoc has a consensus rating of Hold, which is based on 4 buy ratings, 13 hold ratings and 0 sell ratings.

What is Teladoc’s share price target?

The average share price target for Teladoc is 6.60. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €9.10 ,and the lowest forecast is €4.77. The average share price target represents -15.34% Decrease from the current price of €7.8.

What do analysts say about Teladoc?

Teladoc’s analyst rating consensus is a Hold. This is based on the ratings of 17 Wall Streets Analysts.

How can I buy shares of Teladoc?

To buy shares of DE:4LL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Teladoc (4LL) Stock Forecast & Price Target

4LL Analyst Ratings

4LL Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Teladoc

4LL Analyst Recommendation Trends

4LL Financial Forecast

4LL Earnings Forecast

4LL Sales Forecast

4LL Stock Forecast FAQ

Detailed List of Analyst Forecasts